Table 5.
Antioxidants | Model system | Observed effects | Ref. |
---|---|---|---|
Anthocyanidins | Hypercholesterolaemic patients, human stomach cancer cells, human breast cancer cells, human hepato-carcinoma cells. | Suppress PI3K/Akt signaling pathway via epidermal growth factor receptor pathway, or levels of pSGSK3β and β-catenin in a tumor xenograft model. | [163–166] |
Mulberry anthocyanidin | Human liver cancer cells. | Activate PI3K/Akt. | [167] |
Berberine | Human melanoma cells, SD rats. | Inhibit PI3K/Akt and/or GSK3β activities. | [52, 168] |
Murine neural crest cells, murine primary neurons, mice with cerebral and reperfusion, human chondrosarcoma cells. | Increase PI3K/Akt activities and cell growth/survival in other studies. | [169, 170] | |
Curcumin | Human Burkitts’ lymphoma, human esophageal cancer cells, human renal cancer cells. | Enhance radiation- or PI3K/Akt inhibitors-induced or directly induce apoptosis by suppression of PI3K/Akt signaling pathway. | [171–173] |
Rat cardiomyocytes, human prostate cancer cells, Balb/c mice. | Protect cells from apoptosis induced by a high glucose level via upregulation of Akt/GSK3β serine/threonine phosphorylation levels via protein phosphatase-dependent mechanism or inhibits GSK3β activity in vitro or in vivo. | [174–176] | |
Ergosterol | Streptozotocin-induced diabetes in mice, human cancer cells. | Restore PI3K/Akt signaling damaged in diabetic mice; ergosterol-related compounds induce cell apoptosis depending on a protein-promoted Akt activation. | [177, 178] |
Garlicin | Human cellosaurus cells | Suppress PI3K/Akt pathway. | [179] |
Garlic | Fructose-fed diabetic SD rats | Activate PI3K/Akt in Diabetes rats. | [96] |
Luteolin | Human epidermoid carcinoma cells and their murine cells xenograft model, human umbilical vein endothelial cells, human prostate cancer cells, human colon cancer cells, human glioblastoma cells. | Inhibit VEGF-increased PI3K/Akt activities or IGF-1-increased the phosphorylation levels of PI3K/Akt/GSK3 or down-regulate PI3K/Akt pathway. | [180–183] |
Cardiomyocyte in rats with ischemia/reperfusion, murine neural crest cells. | Decrease apoptosis via PI3K/Akt pathway in a rat model or persistently activate Akt in cells. | [184, 185] | |
Lycopene | Prostate epithelial cells. | Inhibit IGF-1-induced Akt/GSK3 serine/threonine phosphorylation levels. | [83] |
Patients, human prostate cells. | Its effects on PI3K/Akt pathway are inhibitory in prostate cancer. | [186] | |
Phytoestrogens | Human embryonic kidney cells, mouse preosteoblastic cells. | Increase phosphorylation levels of Akt and GSK3β as well as the Wnt/β-catenin signaling. | [187] |
Isoflavones | Human cancer cells | Inhibit PI3K/Akt signaling in cancer cells. | [188] |
Soy isoflavone | SD rats with myocardial ischemia/reperfusion. | Gain PI3K/Akt pathway activities in ovariectomized rats. | [189] |
Daidzein or genistein | Nude mice with various tumors | Up-regulate or down-regulate GSK3 gene/protein expression, and both belong to isoflavones. | [190] |
Psoralidin | Human lung fibroblasts, mice. | A coumestan derivative suppresses pro-inflammatory cytokines and regulates PI3K/Akt pathway. | [191] |
Resveratrol | Mouse cardiac fibroblasts, human glioma cells. | Inhibit high glucose-induced PI3K/Akt pathway and inflammation or reduces PI3K/Akt activities. | [63, 192] |
Neural crest cells, APP/PS1 mice. | Protect cells from apoptosis induced by high glucose via activation of PI3K/Akt pathways and increase in vivo pSGSK3β levels. | [193, 194] | |
Lignan including honokiol and sauchinone | Human prostate cancer cells, human myeloid leukaemic cells, mouse microphage, mouse lymphoblast, splenic lymphocytes, human glioma, breast and prostate cancer cells, human hepatocytes, WT and a Nrf2 KO C57/BL6 mice. | Inhibits Akt signaling and generate anti-inflammatory effect via inhibition of PI3K/Akt pathway or mediate suppression of PI3K; however sauchinone, augments in vivo pSGSK3β levels. | [195–198] |
a Nrf2 nuclear factor (erythroid derived 2)-like 2